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Recent studies have indicated that factor Va bound to
activated platelets is partially protected from inactiva-
tion by activated protein C (APC). To explore whether
this sustained factor Va activity could maintain ongoing
thrombin generation, the kinetics of platelet factor Va-
dependent prothrombinase activity and its inhibition by
APC were studied. In an attempt to mimic physiologi-
cally relevant conditions, platelets were adhered to col-
lagen type I-coated discs. These discs were then spun in
solutions containing prothrombin and factor Xa either
in the absence or presence of APC. The experiments
were performed in the absence of platelet-derived mi-
croparticles, with thrombin generation and inhibition
confined to the surface of the adherent platelets. APC
completely inactivated platelet-associated prothrombi-
nase activity with an overall second order rate constant
of 3.3 3 106 M21 s21, which was independent of the pro-
thrombin concentration over a wide range around the
apparent Km for prothrombin. Kinetic studies on pro-
thrombinase assembled at a planar phospholipid mem-
brane composed of 25 mol % phosphatidylserine and 75
mol % phosphatidylcholine revealed a similar second
order rate constant of inhibition (2.5 3 106 M21 s21).
Collectively, these data demonstrate that ongoing plate-
let factor Va-dependent thrombin generation at the sur-
face of collagen-adherent platelets is effectively inhib-
ited by APC. No differences were observed between the
kinetics of APC inactivation of plasma-derived factor Va
or platelet factor Va as part of the prothrombinase as-
sociated with, respectively, a planar membrane of syn-
thetic phospholipids or collagen-adherent platelets.
Activated protein C (APC)1 is a serine protease that inhibits
thrombin formation by limited proteolysis of the nonenzymatic
cofactors factor Va and factor VIIIa of the prothrombin and the
factor X-activating enzyme complex, respectively. Efficient pro-
teolysis of the cofactors requires the presence of membranes
that contain anionic phospholipids, calcium ions, and protein S.
In the presence of membranes that contain negatively charged
phospholipids, plasma factor Va is inactivated by APC-cata-
lyzed cleavage of its heavy chain at Arg306 and Arg506 (1, 2).
The cleavage at Arg506 is relatively rapid and yields a reaction
intermediate that still retains partial cofactor activity in pro-
thrombin activation. The slower cleavage at position Arg306
results in complete loss of cofactor activity (3). The rapid cleav-
age at Arg506 is inhibited when factor Va is in complex with
factor Xa (4–8).
Recently, it was reported that in contrast to synthetic phos-
pholipid membranes, thrombin-activated platelets partially
protect platelet-derived and plasma-derived factor Va from in-
activation by APC. Thrombin-activated platelets appeared to
slow down the cleavage at Arg506 (9). It was speculated that
activated platelets express a membrane component(s) in addi-
tion to anionic phospholipids that specifically binds factor Va
resulting in a factor Va molecule with an apparent APC resist-
ant phenotype (10). This protection of APC-catalyzed inactiva-
tion of factor Va was not observed in the presence of micropar-
ticles or synthetic phospholipid vesicles (9). One of the
questions that remain to be answered is how platelets influence
APC-dependent factor Va inactivation once factor Va is assem-
bled in the prothrombinase complex at the plasma membrane
of activated platelets.
The purpose of the present study was to establish the kinet-
ics of APC-dependent inhibition of ongoing prothrombin acti-
vation at the plasma membrane of platelets adhered to immo-
bilized collagen. To account for transport limitations of
reactants, the experiments were conducted under well defined
flow conditions on a rotating disc. Our findings indicate no
difference in the kinetics of APC-dependent inactivation of
prothrombinase at the membrane of activated, collagen-adher-
ent platelets compared with that at the surface of a planar
phospholipid membrane.
EXPERIMENTAL PROCEDURES
Materials—Bovine serum albumin (BSA), bovine fibrinogen, and
apyrase were from Sigma. S2238, a chromogenic substrate for throm-
bin, was obtained from Chromogenix (Mo¨lndal, Sweden). Human factor
Xa, human prothrombin, and bovine factor Va were prepared and
quantified as described previously (11). Native type I collagen fibrils
were extracted from bovine Achilles tendon in the absence of proteases
using 0.5 M acetic acid and precipitated with 1.7 M NaCl as described
(12). Human a-thrombin was prepared as described previously (13).
Human activated protein C (APC) was purchased from Kordia (Leiden,
The Netherlands). 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC)
and 1,2-dioleoyl-sn-glycero-3-phosphoserine (DOPS) were obtained
from Avanti Polar Lipids (Alabaster, AL). All other reagents used were
of analytical grade.
Platelets—Suspensions of washed human platelets were prepared as
described previously (14). Briefly, blood was drawn from healthy vol-
unteers who had not taken any anti-platelet medication in the preced-
ing 2 weeks. Platelet-rich plasma was prepared by centrifugation. The
platelets were then sedimented by centrifugation and washed twice
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with HEPES buffer (10 mM HEPES, 136 mM NaCl, 5 mM glucose, 2.7
mM KCl, 2 mM MgCl2, 1 mg/ml BSA, and 0.1 units/ml apyrase, pH 6.6).
Finally, the platelets were resuspended in HEPES buffer adjusted to
pH 7.45 (buffer A). Platelets were counted on a Coulter counter
(Coulter, Miami, FL), and the suspensions were adjusted to 5 3 107
platelets/ml.
The Rotating Disc Device—Rotating disc experiments were per-
formed in a device described previously (15). Briefly, a circular glass
coverslip with a diameter of 20 mm (Menzel Gla¨ser, Braunschweig,
Germany), was rotated at 63 rad/s at the bottom of a cylindrical reaction
vessel containing reactants in 3 ml of buffer A. This angular velocity
resulted in a wall shear rate of 3681 s21 at the edge of the rotating
disc. The reaction vessel was pretreated for 1 h with 20 mg/ml BSA in
buffer A.
Preparation of Discs with Collagen-adherent Platelets—Circular
glass coverslips with a diameter of 20 mm were cleaned with a 1:1
mixture of ethanol (96 volume %) and HCl (37 volume %) and subse-
quently rinsed with deionized water. The discs were coated with colla-
gen by incubating the coverslips for 3 h with 300 ml of 0.5 mg/ml
collagen type I in 0.5 M acetic acid. Coated discs were rinsed extensively
with 40 mM phosphate buffer (pH 7.4) containing 0.15 M NaCl and
stored in this buffer until used. Inspection of the discs by phase-contrast
microscopy showed a homogeneous distribution of the collagen fibrils
over the glass surface. The collagen-coated discs were incubated for 15
min with buffer A, followed by a 40-min incubation at room temperature
with 300 ml of a suspension of washed platelets. Nonadherent platelets
were removed by rinsing with buffer A.
Preparation of Phospholipid-coated Discs—Spinning circular glass
coverslips (63 rad/s) were exposed for 20 min to 20 mM vesicles composed
of 25 mol % DOPS and 75 mol % DOPC, prepared as described previ-
ously (16). Fluid phase vesicles were removed by flushing for 5 min (10
ml/min) with buffer A. The phospholipid-coated discs were then trans-
ferred to a reaction vessel containing 3 ml of buffer A for further
experimentation.
Thrombin Generation at Rotating Discs—Discs with collagen-adher-
ent platelets or coated with a phospholipid membrane were spun at 63
rad/s in 3 ml of buffer A containing 3 mM CaCl2. Factor Xa and, when
indicated, factor Va were added, and thrombin generation was started
after 3 min by adding prothrombin. Timed samples (10 ml) were taken
and transferred to cuvettes with 440 ml of Tris buffer (50 mM Tris-HCl,
175 mM NaCl, 0.5 mg/ml BSA, pH 7.9) containing 20 mM EDTA. Throm-
bin was assayed by adding 2.4 mM S2238 (50 ml) to the cuvette. The
change in optical density was monitored at 405 nm. The thrombin
concentrations in the samples were calculated from a standard curve
obtained with known amounts of the enzyme. All procedures were
performed at 37 °C.
Assay for Procoagulant Microvesicles—Samples (10 ml) from the re-
action vessel were added to cuvettes containing factor Xa, factor Va, and
3 mM CaCl2 in 137 ml of Tris buffer. After a 3-min incubation, thrombin
generation was started by adding 3 ml of prothrombin. The final con-
centrations were: 1 pM factor Xa, 0.5 nM factor Va, and 200 nM pro-
thrombin. Thrombin generation was stopped after 5 min by the addition
of Tris-EDTA buffer and assayed as described. A reference curve was
constructed using different phospholipid vesicle (25 mol % DOPS, 75
mol % DOPC) concentrations and was linear up to 1 mM.
Kinetic Data Analysis of Time Courses of APC-dependent Inactivation
of Prothrombinase—The rate of thrombin generation at the surface of
the rotating disc decreases in time especially when prothrombin con-
centrations are used below the apparent Km for prothrombin. Thrombin
generation in the presence of APC was therefore corrected for substrate
depletion by assuming an APC-independent pseudo first order rate
constant of inactivation, k1, utilizing the equation
@thrombin#t 5 V0~1 2 e2k1t!/k1 (Eq. 1)
in which [thrombin]t is the thrombin concentration at time t, and V0 the
initial rate of thrombin formation. Inhibition of prothrombin activation
in the presence of APC was analyzed according to
@thrombin#t 5 @thrombin#ti 1 V0e
2k1ti~1 2 e2~k21k1!~t2ti!!/~k2 1 k1!
for t . ti (Eq. 2)
with ti the time at which APC was added to the reaction and k2 the
APC-dependent pseudo first order rate constant of prothrombin activa-
tion inhibition. Values for V0, k1, and k2 were estimated by a least
square fit of Equations 1 and 2 to the experimental data obtained from
thrombin generation experiments performed in the absence or presence
of APC.
RESULTS
Thrombin Formation at the Plasma Membrane of Collagen-
adherent Platelets—Platelet adhesion on immobilized collagen
in the presence of extracellular calcium is accompanied by the
shedding of microparticles and exposure of negatively charged
phospholipids in the outer leaflet of the plasma membrane (14).
These microparticles may provide a procoagulant surface that
supports prothrombin activation and thus could complicate our
study on the kinetics of APC-dependent inactivation of pro-
thrombin activation at the surface of collagen-adherent plate-
lets. Therefore, initial experiments were conducted to establish
the extent of microvesiculation and their contribution to pro-
thrombin activation and, when necessary, to redesign the ex-
periment in such a way that the contribution of microparticles
to prothrombin activation would be negligible.
Coverslips with collagen-adherent platelets were spun in
buffer A, and after 12 min CaCl2 (3 mM) was added. Samples
were taken from the reaction vessel and assayed for procoagu-
lant vesicles. Fig. 1 shows that immediately after the addition
of calcium the concentration of solution phase procoagulant
phospholipid increased, reaching a maximum after 30–40 min.
To investigate the relative contributions of these microparticles
and the collagen-adherent platelets to prothrombin activation,
factor Xa (50 pM) followed 3 min later by prothrombin (100 nM)
were added to the reaction vessel. Immediately after the addi-
tion of prothrombin an aliquot (100 ml) was taken from the
reaction vessel, transferred to a test tube, and incubated at
37 °C. Timed samples were taken from both the reaction vessel
and the test tube and assayed for thrombin activity. The rates
of thrombin generation were 2.2 and 1.3 nM/min in the reaction
vessel and test tube, respectively, demonstrating that mi-
crovesicles and adherent platelet contributed about equally to
thrombin generation (Fig. 2). In the second step of this exper-
iment the reaction vessel was flushed for 5 min (10 ml/min)
with buffer A containing 3 mM CaCl2 to remove microparticles.
After the re-addition of factor Xa (50 pM) followed by prothrom-
bin (100 nM) no thrombin generation could be detected in the
fluid phase. This finding indicated that procoagulant micropar-
ticles were absent and that thrombin-generating activity was
now solely confined to the spinning surface with collagen-ad-
herent platelets (Fig. 2). The rate of thrombin generation (0.3
nM/min) was, however, lower than the rate of thrombin gener-
ation at the spinning surface before the removal of micropar-
ticles (0.9 nM/min). The combined results of three similar ex-
periments showed that the rinsing step decreased the surface-
associated thrombin production by 59 6 10% (mean 6 S.D.).
This loss of activity was most likely due to a loss of platelet-
FIG. 1. Extracellular calcium-induced shedding of procoagu-
lant microvesicles. A collagen-coated circular glass coverslip with
adherent platelets was spun at 63 rad/s in calcium-free buffer A (pH
7.4). At the indicated time (arrow) 3 mM CaCl2 was added. Timed
samples were taken and assayed for procoagulant activity as described
under “Experimental Procedures.”
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associated factor Va activity because addition of plasma-de-
rived factor Va (1 nM) resulted in an increase in the rate of
thrombin generation from 0.3 to 1.8 nM/min. All further exper-
iments were performed with discs containing collagen-adher-
ent platelets that were first spun for 30 min at 63 rad/s in
buffer A containing 3 mM CaCl2 and then flushed with the same
buffer for 5 min at 10 ml/min to remove microparticles prior to
thrombin generation.
Optimization of Thrombin Generation at the Plasma Mem-
brane of Collagen-adherent Platelets—Fig. 3 shows the initial
rates of thrombin generation at a fixed prothrombin concentra-
tion (100 nM) as a function of the factor Xa concentration. The
apparent dissociation constant, Kd, of surface-bound factor Xa
is described by the simple single site binding isotherm, Vobs 5
Vmax [Xa]/([Xa] 1 Kd), with Vobs the initial rate of thrombin
formation, [Xa] the factor Xa concentration, and Vmax the ini-
tial rate of thrombin generation at saturating factor Xa con-
centration. The value for the apparent Kd estimated by fitting
this equation to the data from two similar experiments is 3.5 6
0.9 pM (estimated value 6 1 S.E.). Further experiments were
performed at a saturating concentration of factor Xa (50 pM).
Fig. 4 shows the prothrombin dependence of thrombin gen-
eration at the surface of collagen adherent platelets in the
presence of 50 pM factor Xa. The data could be described ade-
quately by the Michaelis-Menten equation, Vobs 5 Vmax [pro-
thrombin]/([prothrombin] 1 Km,app), in which Vmax is the ini-
tial rate of thrombin formation at a saturating prothrombin
concentration, [prothrombin] the prothrombin concentration in
free solution, and Km(app) is the apparent Michaelis constant.
The solid line in Fig. 4 represents the best fit of this equation to
the experimental data. The combined result of two similar
experiments yielded a Km(app) of 42 6 5 nM (estimated value 6
1 S.E.).
APC-dependent Inhibition of Thrombin Formation at the
Plasma Membrane of Collagen-adherent Platelets during On-
going Prothrombin Activation—The results of a typical pro-
thrombinase inactivation experiment at the surface of collagen-
adherent platelets are shown in Fig. 5. The first 8 min of the
experiment was performed in the absence of APC to enable the
determination of the initial rate of thrombin formation, V0.
Upon the addition of APC, the rate of thrombin formation
rapidly decreased. To visualize the concentration-dependent
effect of APC, a considerable interdisc variation in the rate of
thrombin generation (0.5–1.2 nM/min) was corrected by setting
the initial rates in the absence of APC to the same value. The
total time courses of thrombin generation in the absence or
presence of APC were analyzed by a least squares fit according
to Equations 1 and 2 as described under “Experimental Proce-
dures.” The first order rate constant of inhibition as a function
of the APC concentration is shown as an insert on Fig. 5. The
APC-dependent inactivation of prothrombinase obtained from
these data was 3.3 3 106 M21 s21.
To assess the influence of the prothrombin concentration on
the inhibition of the prothrombinase activity, comparable inhi-
bition experiments were performed at prothrombin concentra-
tions ranging from 20 to 500 nM. The results presented in Table
I show that varying the prothrombin concentration did not
influence the pseudo first order rate constant of inactivation of
platelet-associated prothrombinase activity.
The inhibition of prothrombinase activity by APC at a plate-
FIG. 2. Platelet surface and microvesicle-associated thrombin
generation. A collagen-coated coverslip with adherent platelets was
spun at 63 rad/s for 30 min in buffer A containing 3 mM CaCl2. Factor
Xa (50 pM) was added followed by prothrombin (100 nM) to start throm-
bin generation. Immediately after the addition of prothrombin an ali-
quot (100 ml) was taken and incubated at 37 °C. Timed samples were
taken from both the rotating disc reaction vessel and the removed
aliquot to determine, respectively, the rate of total thrombin generation
(l ) and the rate of fluid phase thrombin generation (E). After 10 min
the reaction vessel was flushed with 3 mM CaCl2-containing buffer A for
5 min at 10 ml/min. Factor Xa (50 pM) and prothrombin (100 nM) were
re-added. An aliquot (100 ml) was taken from the reaction vessel and
further incubated at 37 °C. Timed samples from the reaction vessel ()
as well as from the incubation mixture () were assayed for thrombin.
FIG. 3. Rate of thrombin formation at collagen-adherent plate-
lets as a function of factor Xa concentration. A disc with collagen-
adherent platelets was spun in buffer A containing 3 mM CaCl2 and 100
nM prothombin. The initial rates of thrombin formation were measured
for increasing concentrations of factor Xa. The solid line is the result of
the fit procedure described under “Results.”
FIG. 4. Rate of thrombin formation at collagen-adherent plate-
lets as a function of the prothrombin concentration. A disc with
collagen-adherent platelets was spun in buffer A containing 3 mM CaCl2
and 50 pM factor Xa. The initial rates of thrombin formation were
measured for increasing concentrations of prothrombin. The solid line
is the result of the fit procedure described under “Results.”
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let surface was compared with that at a rotating planar phos-
pholipid membrane composed of 25 mol % DOPS and 75 mol %
DOPC. The experimental conditions for thrombin generation
and inhibition were the same as described for collagen-adher-
ent platelets. However, in addition to factor Xa (50 pM) and
prothrombin (100 nM), plasma factor Va (10 pM) also was added.
Typical thrombin generation curves in the absence or presence
of APC are shown in Fig. 6. Thrombin generation was analyzed
by a least squares fit of Equations 1 and 2 to the data. A plot of
the first order rate constants of inactivation as a function of the
APC concentration is shown as an insert on Fig. 6. Linear
regression to these data yielded a second order rate constant of
inhibition of prothrombin activation of 2.5 3 106 M21 s21.
DISCUSSION
It is generally believed that upon vessel wall injury the
adhesion of platelets to exposed collagen stimulates thrombus
formation. The interaction between platelets and immobilized
collagen induces the release of the content of the a-granula,
exposure of anionic phospholipids, and shedding of mi-
crovesicles. As a result, highly reactive procoagulant platelets
and microvesicles are generated in which factor Va from
a-granula (17, 18) and anionic phospholipids (12) provide the
essential accessory factors for the prothrombin-converting en-
zyme factor Xa.
This study focuses on the role of APC as an inhibitor of
ongoing thrombin generation at the surface of collagen-adher-
ent platelets. To account for the transport-limited supply of
substrate at these surfaces (19, 20) and to approach the in vivo
situation of thrombin formation under flow conditions, activa-
tion and inactivation experiments were performed utilizing
saturating factor Xa and prothrombin concentrations in a pre-
viously described rotating disc device (15, 20–22).
Thrombin Generation at the Surfaces of Collagen-adherent
Platelets—Initial experiments confirmed that platelet adhesion
to collagen in the presence of extracellular calcium resulted in
the formation of microparticles. As a matter of fact, about 60%
of total thrombin generation could be attributed to prothrom-
binase associated with these microparticles. Because this study
was focused on ongoing thrombin generation at adherent plate-
lets, subsequent experiments were performed after the micro-
particles were removed from the reaction system.
To further characterize the kinetics of thrombin generation
at the surfaces of collagen-adherent platelets, dependence on
factor Xa and prothrombin concentration was determined. The
apparent Kd for factor Xa on collagen-adherent platelets was
3.5 pM. We note that this Kd value is determined in the pres-
ence of a fixed prothrombin concentration (100 nM) but in the
absence of both microvesicles and exogenous factor Va. Much
higher apparent Kd values for factor Xa have been reported for
thrombin-activated platelets in suspension (Kd 5 142 pM) (24)
and for von Willebrand factor-adherent platelets (Kd 5 4 nM)
(25), but the value found here is in close agreement with the
value of 1 pM reported for the interaction of factor Xa with
planar phospholipid surface composed of 25% PS, 75% PC and
containing preabsorbed factor Va (23).
The prothrombin concentration in the solution required to
obtain a half-maximal rate of thrombin generation was 42 nM.
This apparent Km value is lower than the value reported for
vesicles in suspension (Km 5 100 nM) (26) but higher than the
values of 5 and 7 nM for phospholipid bilayers in a tubular flow
system (11) and for prothrombin activation experiments on
rotating discs (20), respectively. However, the values reported
for the tubular flow reactor were obtained after correction for
prothrombin depletion near the catalytic surface. If the same
correction is made here, a Km value of 14 nM would be obtained.
Interestingly, the plasma prothrombin concentration is more
than 100-fold higher, meaning that inhibitors like antithrom-
FIG. 5. APC-dependent inactivation of prothrombinase activ-
ity associated with collagen-adherent platelets. Discs with colla-
gen-adherent platelets were spun in buffer A containing 3 mM CaCl2, 50
pM factor Xa, and 100 nM prothrombin. Timed samples were removed
and assayed for thrombin. At the indicated time (arrow) a small aliquot
of buffer (l ) or 0.25 nM (E), 0.5 nM (), or 1 nM APC () was added. The
initial rates of thrombin formation in the absence of APC were set to the
same value. The solid lines represent the best fit of Equations 1 and 2
to the data. The first order rate constants of inhibition thus obtained
are shown as a function of the APC concentration in the insert.
TABLE I
Effect of prothrombin concentration on APC-catalyzed inhibition of
prothrombinase activity
Discs with collagen-adherent platelets were spun in buffer A contain-
ing 3 mM CaCl2, 50 pM factor Xa, and the indicated prothrombin con-
centrations. After 3 min, 0.5 nM APC was added, and the pseudo first
order rate constants of inhibition by APC were calculated by fitting the
thrombin generation data as described under “Experimental Proce-
dures.”
Prothrombin concentration Rate constant of inhibition
nM min21
20 0.07
50 0.07
100 0.08
200 0.05
500 0.07
FIG. 6. APC-dependent inactivation of prothrombinase activ-
ity associated with a synthetic phospholipid membrane. Rotat-
ing discs with planar phospholipid membranes composed of 25 mol %
DOPS and 75 mol % DOPC were spun in buffer A containing CaCl2 (3
mM), factor Xa (100 pM), and factor Va (10 pM). After 5 min thrombin
generation was started by the addition of prothrombin (100 nM). At the
indicated time (arrow) a small aliquot of buffer (l ) or 0.5 nM (E), 1 nM
(), or 2 nM APC () was added. Timed samples were removed and
assayed for thrombin. The solid lines represent the best fit of Equations
1 and 2 to these data. The first order rate constants of inhibition thus
obtained are shown as a function of the APC concentration in the insert.
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bin will have no chance to compete successfully with prothrom-
bin for the active site of prothrombinase (27, 28). It is, there-
fore, unlikely that proteinase inhibitors like antithrombin can
regulate platelet-associated prothrombinase activity.
APC-dependent Inhibition of Ongoing Thrombin Generation
at Adherent Platelets—It has been shown that platelets greatly
accelerate the rate of APC-dependent inactivation of factor Va
by providing a negatively charged phospholipid surface (29).
However, it has also been reported that platelets show an
APC-resistant phenotype. That is, despite the presence of APC,
platelet-derived factor Va activity is sustained on the surface of
thrombin-activated platelets (9–10, 30–31). The present report
demonstrates that APC inhibits platelet-associated prothrom-
binase activity in a mono-exponential way with a second order
rate constant of inactivation of 3.3 3 106 M21 s21. This value is
in excellent agreement with the second order rate constant of
inhibition (2.5 3 106 M21 s21) found for prothrombinase asso-
ciated with a planar synthetic phospholipid membrane com-
posed of 25 mol % PS, 75 mol % PC. Moreover, the inhibition
rates reported here for ongoing thrombin generation are also
very close to the reported (32) rate constant for APC-catalyzed
cleavage at Arg306 in plasma-derived factor Va (k 5 6.5 3 106
M21 s21).
Thus, in the experimental setup of the present study, which
mimics physiologically relevant conditions, we observed com-
plete inactivation by APC of the prothrombin-converting activ-
ity of the factor Va-factor Xa complex bound to collagen-adher-
ent platelets. Moreover, no differences were found between the
first order rate constant of inactivation of prothrombinase as-
sembled at collagen-adherent platelets and at a synthetic phos-
pholipid membrane. In contrast, Camire et al. (9) found differ-
ent kinetics for the inactivation of factor Va at platelets and
synthetic phospholipid membranes, with a slower, and most
importantly, incomplete inactivation of factor Va at the mem-
brane of platelets. We note that these investigators used
thrombin-activated platelets and that the decline of factor Va
cofactor activity was assayed from timed samples as prothrom-
binase activity using a high factor Xa concentration. Thrombin,
however, has been demonstrated to be a rather weak agonist in
inducing exposure of negatively charged phospholipids (PS) in
the outer leaflet of the platelet plasma membrane (14, 33). In
addition, Camire et al. (9) prevented thrombin-activated plate-
lets from aggregation by using the RGDS peptide and did not
stir the platelet suspension. It was recently reported that these
conditions prevent thrombin-induced exposure of PS (34). In
view of the stimulating role of negatively charged phospholip-
ids on the kinetics of the cleavage of factor V at Arg306 (32), it
is tempting to speculate that under their experimental condi-
tions (9), insufficient platelets provide the suitable surface to
bind factor Va and to stimulate APC activity. Although this
notion would explain the finding that part of the factor Va
escaped inactivation, it is contradicted by their observation
that exogenous plasma-derived factor Va added to a thrombin-
activated platelet suspension was rapidly inactivated (9).
Recently, it was reported that prothrombin dramatically in-
hibits the ability of APC to inactivate factor Va but scarcely
inhibits the inactivation of factor VaLeiden (35). Moreover, it
was suggested that prothrombin inhibits the cleavage at both
Arg506 and Arg306. In contrast, our experiments clearly dem-
onstrate that the rate of inactivation of platelet-bound pro-
thrombinase by APC is not slowed down even under conditions
that result in full saturation of the prothrombinase complex
with its substrate prothrombin (cf. Fig. 4, Table I). At present
we have no explanation for these deviating results.
In summary, our data show that APC is an efficient inhibitor
of platelet-dependent thrombin generation. The half-life of pro-
thrombinase in the presence of 1 nM APC and under the con-
ditions of the experiment is 5 min. Whereas it has been re-
ported that platelet-bound factor Va is resistant to APC, our
results clearly indicate that platelet-bound factor Va, as part of
the prothrombinase complex, is inactivated by APC with a rate
that is comparable with that found on a membrane of synthetic
phospholipids. Sustained platelet-derived factor Va cofactor
activity therefore could be less critical than proposed (9, 10).
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